Sign up free

UNITED THERAPEUTICS Corp (UTHR) insider trading

No open-market insider purchases of UNITED THERAPEUTICS Corp are on record; 39 open-market sales are.

Follow UTHR, freeOpen the live feed

A free account gets an alert the minute a new buy or sale is filed.

−$186Mnet insider buying, 90 days
−$186Mnet insider buying, 12 months
0 · 3insiders buying · selling, 12 months
—no buys on record

Insider purchases

No open-market purchases on record.

Insider sales

39 open-market sales on record
FiledInsiderSold
Oct 30
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.7M
9,500 at $594.78
Oct 29
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.6M
9,500 at $585.49
Oct 28
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.6M
9,500 at $587.73
Oct 27
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.6M
9,500 at $588.64
Oct 26
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.5M
9,500 at $582.76
Oct 23
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.5M
9,500 at $583.38
Oct 22
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.3M
9,500 at $560.07
Oct 21
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.3M
9,500 at $553.87
Oct 20
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.2M
9,500 at $543.32
Oct 19
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.1M
9,500 at $534.66
Oct 16
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.2M
9,500 at $546.65
Oct 16
Form 4 (opens sec.gov)
Paul A. MahonOfficer · planned (10b5-1) · option shares $4.5M
8,300 at $544.30
Oct 15
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.1M
9,500 at $539.99
Oct 14
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.2M
9,500 at $545.52
Oct 13
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.2M
9,500 at $550.70
Oct 13
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.2M
9,500 at $544.94
Oct 9
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.1M
9,500 at $534.31
Oct 8
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.2M
9,500 at $548.95
Oct 7
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.1M
9,500 at $538.67
Oct 6
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.1M
9,500 at $541.64
Oct 5
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.2M
9,500 at $549.37
Oct 2
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $5.5M
9,500 at $576.47
Oct 1
Form 4 (opens sec.gov)
Paul A. MahonOfficer · planned (10b5-1) · option shares $4.7M
8,300 at $564.95
Oct 1
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) $1.1M
1,920 at $550.22 · 0% of holdings
Oct 1
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $3.9M
7,580 at $517.97
Sep 30
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $4.5M
9,500 at $477.42
Sep 29
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $4.6M
9,500 at $480.85
Sep 28
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $4.5M
9,500 at $476.17
Sep 25
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $4.5M
9,500 at $473.55
Sep 24
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $4.7M
9,500 at $491.57
Sep 23
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $4.7M
9,500 at $494.83
Sep 22
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $4.7M
9,500 at $494.55
Sep 21
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $4.7M
9,500 at $494.79
Sep 18
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $4.7M
9,500 at $496.06
Sep 18
Form 4 (opens sec.gov)
Paul A. MahonOfficer · planned (10b5-1) · option shares $4.1M
8,300 at $497.54
Sep 17
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $4.8M
9,500 at $501.39
Sep 16
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $4.8M
9,500 at $501.59
Sep 15
Form 4 (opens sec.gov)
Martine A. RothblattChair · planned (10b5-1) · option shares $4.8M
9,500 at $504.12
Sep 15
Form 4 (opens sec.gov)
Nilda MesaDirector $115k
228 at $505.87

Most insider sales are planned in advance or made for personal reasons, so a sale says less than a buy.

Planned insider sales of UTHR (Form 144)

FiledInsiderTo sell
Oct 15
Form 144
PAUL MAHONOfficer · 10b5-1 plan$4.5M
8,300 shares from Oct 15

A Form 144 is filed before an insider sells restricted or control shares; the Form 4 reports the sale once made.

Questions

Are insiders buying UTHR stock?

Not recently: no open-market purchases were filed in the last 90 days.

Who bought UTHR stock most recently?

No insider has bought UTHR on the open market in the filings on record.

How does InsiderBeacon score an insider buy?

Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.

Data as of Oct 30, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer

Follow insiders. Sell when they sell.Free in early access, no card

Sign up free